Phase
Condition
Diabetes And Hypertension
Diabetes Prevention
Diabetes Mellitus Types I And Ii
Treatment
VX-264
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria:
Clinical history of T1D with greater than or equal to (>=) 5 years duration Participant is on a stable diabetic treatment Consistent use of continuous glucose monitoring (CGM) for at least 4 weeks before Screening and willingness to use CGM for the duration of the study
Exclusion
Key Exclusion Criteria:
Prior islet cell transplant, organ transplant, or cell therapy
Study Design
Connect with a study center
University of Alberta, Edmonton
Edmonton,
CanadaSite Not Available
Montreal Clinical Research Institute
Montreal,
CanadaSite Not Available
Toronto General Hospital (TGH)
Toronto,
CanadaSite Not Available
Vancouver General Hospital
Vancouver,
CanadaSite Not Available
Dresden Center for Islet Transplantation
Dresden,
GermanySite Not Available
IRCCS Ospedale San Raffaele
Milan,
ItalySite Not Available
Leiden University
Leiden,
NetherlandsSite Not Available
Hopiteaux Universitaires de Geneve
Geneve,
SwitzerlandSite Not Available
Churchill Hospital
Headington,
United KingdomSite Not Available
Royal Victoria Infirmary
Newcastle Upon Tyne,
United KingdomSite Not Available
UHealth Diabetes Research Institute
Miami, Florida 33136
United StatesSite Not Available
University of Chicago
Chicago, Illinois 60637
United StatesSite Not Available
Massachusetts General Hospital
Boston, Massachusetts 02114
United StatesSite Not Available
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania 19104
United StatesSite Not Available
University of Pittsburgh Medical Center Montefiore
Pittsburgh, Pennsylvania 15213
United StatesSite Not Available
University of Wisconsin
Madison, Wisconsin 53792
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.